Formulation Foundations: A Peak Behind the Development Curtain
Dr. David Osborne
Finding the right formulation is not always a fun endeavor for the practitioner or patient, and can be the make or break for patient adherence. In fact, an active ingredient without a thoughtful, purposeful, clinically translatable vehicle is like peanut butter without jelly ( though for us PB lovers who eat it from a spoon maybe that’s not the best analogy). But how are we to think critically about the lotion or potion in which our cutting edge topical therapies are suspended/dissolved when this is not part of our training or CME? No need to answer because we’ve got the C.R.E.A.M. Joining podcast host Dr. Adam Friedman is formulation foreman Dr. David Osborne, Chief Technical Officer at Arcutis Therapeutics. Let’s just say there is a really good chance you have prescribed something my man has invented over the past several decades. Uncap your knowledge gap and tune in to learn about key vehicle considerations to keep your form in check.
This podcast is funded by Arcutis Therapeutics.
Listen Now
HOST: Adam Friedman, MD, FAAD
GUEST: Dr. David Osborne
You May Also Like
Guest: Douglas DiRuggiero Corticosteroids remain one of dermatology’s most reliable workhorses, but good stewardship isn’t about putting the horse out to pasture. It’s about knowing when to ride, when to…
Guest: Dr. Joseph Bax Corticosteroid injections are everywhere in musculoskeletal medicine. Epidurals, joints, facets, bursae: when inflammation and pain are the targets, steroids have long been one of the sharpest…
Guest: Dr. Tae Oh For too long, the therapeutic ladder in hidradenitis suppurativa has often looked less like a ladder and more like an uneven mound: try this, fail that,…
Get More from the JDD Podcast
Get the latest dermatology news delivered straight to your Inbox – sign up for the JDD Newsletter.
Discover the latest research, exclusive articles from leading dermatology experts,popular Podcast episodes, free CME activities, and more!
Subscribe
Podcast: Play in new window | Download
Subscribe: RSS
